Status:
COMPLETED
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Colorectal Cancer
Colorectal Carcinoma
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
Colorectal Carcinoma (CRC) is the third most frequent diagnosed cancer worldwide, with 1.4 million new cases every year. In an attempt to reduce this number many countries have implemented a nationwid...
Detailed Description
INTRODUCTION AND RATIONALE Colorectal Cancer (CRC) is the third most frequent diagnosed cancer worldwide, with 1.4 million new cases every year. Mortality of CRC is estimated at around 40%. To reduce ...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, a screening invitee must meet the following criteria:
- The screening invitee must be at least 55 years old, and no older than 75 years old, at the day of invitation by the Foundation of Population Screening Mid-West
- The screening invitee must be eligible for participation in the second round of the Dutch CRC Population Screening Programme
- The screening invitee must return a signed informed consent form
Exclusion
- A potential screening invitee who meets any of the following criteria will be excluded from participation in this study:
- if he or she receives active treatment for CRC and/or AN, including palliative care.
- if he or she fails to return a sample that is adequate for FIT testing.
Key Trial Info
Start Date :
December 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
6753 Patients enrolled
Trial Details
Trial ID
NCT04490551
Start Date
December 5 2019
End Date
June 1 2021
Last Update
August 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, locatie Academisch Medisch Centrum
Amsterdam, North Holland, Netherlands, 1105 AZ